Skip to content

Jennifer E. Cook, Director at BridgeBio Pharma, sold BBIO on Jun 15, 2026

Data as of Oct 16

▼ SELL$101K1,503 shares at $67.14Jennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.
Watch BBIO
Traded
Jun 15, 2026
Disclosed
Jun 17, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jennifer E. Cook, Director at BridgeBio Pharma, sold BBIO on Jun 15, 2026TRADEDDISCLOSED
BBIOSimilar stocks (XLV — its sector index fund), rebased to BBIO's price on the disclosure day
BBIO since disclosure
−1.5%
after the sale
Similar stocks (XLV) since disclosure
+17.3%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.$5.9Mdisclosed Jun 17 · filed 2 days after the trade

See every trade on BBIO →